The biotechnology sector offers investors a high-risk, high-reward opportunity as companies race to bring breakthrough therapies to market. Here are three standout stocks that should be on your watchlist in 2026, according to Barchart ratings. Each of these three biotech stocks offers varying risk profiles and development timelines for investors willing to bet on medical innovation. More News from Barchart Best High-Risk Biotech Stocks for 2026 #1: Ligand Pharmaceuticals (LGND) Ligand Pharmaceuticals ...